Medical Investment with Long Term Blue Chip Tenant
JLL is excited to present to the market a rare opportunity to acquire a premium Rockhampton CBD medical investment with long term secure covenant, key attributes include:
• Purpose built Pathology Laboratory.
• 100% Leased to QML Pathology Laboratory, a subsidiary of Primary Healthcare - one of Australia’s Largest Healthcare companies.
• New secure lease to 2022 with options to 2032.
• Strategic location in Rockhampton CBD.
• Passing Net Income of $210,107.
Expressions of Interest
Date and Time: